Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/1996
10/03/1996WO1996029974A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/03/1996WO1996029973A2 Compositions and methods for inhibiting thrombogenesis
10/03/1996WO1996026285A3 Methods and compositions for administering gene therapy vectors
10/03/1996WO1996024348A3 Use of carbazole compounds for the treatment of congestive heart failure
10/03/1996WO1994004702A3 Improved detection and therapy of lesions with biotin/avidin conjugates
10/03/1996CA2805588A1 Vascular endothelial cell growth factor antagonists
10/03/1996CA2754887A1 Vascular endothelial cell growth factor antagonists
10/03/1996CA2216807A1 Diagnostic and therapeutic system for crohn's disease and colitia ulcerosa
10/03/1996CA2216806A1 Insulin mimetic and enhancer assay
10/03/1996CA2216651A1 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/03/1996CA2216278A1 Transdermally administrable medicament with ace inhibitors
10/03/1996CA2214499A1 Gene transfer into the kidney
10/02/1996EP0734730A1 Use of a CGRP antagonist for the treatment of ocular or eyelid pruritis and disesthesies
10/02/1996EP0734729A1 Use of a CGRP antagonist for the treatment of cutaneous erythema of neurogenic origin and so obtained composition
10/02/1996EP0734728A1 Use of a CGRP antagonist for the treatment of lichens and pruritis and composition so obtained
10/02/1996EP0734721A2 Method of incorporating drugs into a polymer component of stents
10/02/1996EP0734440A1 Tumor cell fusions and methods for use of such tumor cell fusions
10/02/1996EP0734395A1 Interleukin-1 receptor antagonist decreases severity of acute pancreatitis
10/02/1996EP0734267A1 Aqueous topical compositions
10/02/1996EP0734264A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
10/02/1996EP0734263A1 ALPHAvBETA3 INTEGRIN AS A PREDICTOR OF ENDOMETRIOSIS
10/02/1996EP0734248A1 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
10/02/1996EP0681434B1 Rehydration drink
10/02/1996EP0480054B1 Percutaneously absorbable composition of morphine hydrochloride
10/02/1996DE19512181A1 Transdermal applizierbares Arzneimittel mit ACE-Hemmern Transdermally administrable drug with ACE inhibitors
10/01/1996US5561160 Administering glucaric acid or salt thereof
10/01/1996US5561159 Topical applying to face
10/01/1996US5561158 Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging
10/01/1996US5561157 Method for enhancing the therapeutic effect of a composition comprising hydroquinone and comprising same
10/01/1996US5561156 Method of treating wrinkles using methyllactic acid
10/01/1996US5561155 Method of treating wrinkles using galacturonic acid or galacturonolactone
10/01/1996US5561153 Method of treating wrinkles using mucic acid or mucolactone
10/01/1996US5561149 For nasal administration
10/01/1996US5561141 MDR reversal agents
10/01/1996US5561124 Reducing prostate size; anticarcinogenin agents for adenocarcinoma; lowering levels of dihydrotestosterone; inconjuction with prescribed drugs in treating acne, seborrhea, hirsutism and alopecia
10/01/1996US5561050 Methods for diagnosis of colon, stomach and pancreatic cancer using antibodies specific for a mucin-type carbohydrate chain
10/01/1996US5561043 Genetic engineering
10/01/1996US5560935 Administering to inhibit plasma kallikrein production: improves peripheral blood flow, exhibits analgesic, antiinflammatory and antiallergic properties
09/1996
09/26/1996WO1996029417A1 Il-13 receptor specific chimeric proteins and uses thereof
09/26/1996WO1996029407A2 Cellubrevin homologs
09/26/1996WO1996029404A1 HUMAN METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE mGluR6
09/26/1996WO1996029341A1 Human stat4
09/26/1996WO1996029080A1 Poly(hydroxy acid)/polymer conjugates for skin applications
09/26/1996WO1996029074A1 Methods of treating or preventing pain or nociception
09/26/1996WO1996029066A1 Prilocaine and hydrofluorocarbon aerosol preparations
09/26/1996WO1996024373A3 Combination of angiotensin converting enzyme inhibitor and side-effect-reduced amount of aldosterone antagonist
09/26/1996WO1996024372A3 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic
09/26/1996CA2216147A1 Cellubrevin homologs
09/26/1996CA2215730A1 Human metabotropic glutamate receptor subtype mglur6
09/26/1996CA2215122A1 Il-13 receptor specific chimeric proteins and uses thereof
09/25/1996EP0733366A2 Pharmaceutical compositions comprising angiotensin II receptor blocking imidazoles and diuretics
09/25/1996EP0733072A1 Antibody against carcinoembryonic antigen (cea)
09/25/1996EP0733071A1 Antagonists to chaperonin 10
09/25/1996EP0733066A1 Pretargeting methods and compounds
09/25/1996EP0732943A1 Three-step pretargeting methods and compounds
09/25/1996EP0732938A1 Method of treating intestinal disorders
09/25/1996EP0732926A1 Pharmaceutical formulation for preventing or pre-treating poisoning by organophosphoric cholinesterase inhibitors
09/25/1996EP0732924A1 Transdermal therapeutical system for preventing poisoning by organophosphoric nurotoxins that consists of a combination of active substances including a parasympathomimetic and a parasympatholytic agent
09/25/1996EP0732923A1 Pharmaceutical compositions containing hiv protease inhibitors
09/25/1996EP0732915A1 Local delivery of fibrinolysis enhancing agents
09/25/1996EP0732875A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
09/25/1996EP0674513B1 Retroviral protease inhibiting compounds
09/25/1996CN1131539A Treatment of disease and conditions associated with macrophage infiltration
09/25/1996CN1032841C Method for preparing antiacid effervescent couples
09/24/1996US5559158 Pharmaceutical composition
09/24/1996US5559151 Method for reducing intraocular pressure in the mammalian eye by administration of chloride channel blockers
09/24/1996US5559135 Treatment of cardiovascular disorders, hypotensive agents, antiinflammatory agents or antiasthmatics
09/24/1996US5558987 Anxiolytic drug as stress relievers by reducing blood cholecystokinin
09/19/1996WO1996028187A1 Method for treating amyloidosis
09/19/1996WO1996028186A1 Use of g class immunoglobulins for the topical treatment of atopic dermatitis
09/19/1996WO1996028185A2 Composition containing amlodipine, or a salt, or felodipine and an ace inhibitor
09/19/1996WO1996028167A1 Compositions comprising nicotynylalanine and an inhibitor of glycine conjugation or vitamin b6
09/19/1996WO1996028163A1 Adenosine as a positive inotrop in the compromised heart
09/19/1996WO1996028154A2 Use of anti-oestrogens as male contraceptives
09/19/1996WO1996028151A2 Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs
09/19/1996WO1996028148A2 Use of a r-nsaid in a protective composition for the treatment of colorectal cancer
09/19/1996WO1996028145A1 Use of nitric oxide donors or nitric oxide inhibitors for regulating cervical dilatation and extensibility
09/19/1996WO1996028144A1 Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
09/19/1996WO1996028142A1 Method and kit for preventing erectile dysfunction
09/19/1996WO1996028114A1 Antioxidant-induced apoptosis in vascular smooth muscle cells
09/19/1996WO1996028029A1 Immunoisolation
09/19/1996WO1996019499A3 Improved cyclic crf antagonists
09/19/1996WO1996019233A3 Irrigation solution and method for inhibition of pain, inflammation and spasm
09/19/1996DE19510862A1 Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle Use of antiestrogens for male birth control
09/19/1996CA2215373A1 Use of antiestrogens for male birth control
09/19/1996CA2215307A1 Pharmaceutical compositions and kits for preventing erectile dysfunction
09/19/1996CA2215039A1 Immunoisolation
09/19/1996CA2214823A1 Antioxidant-induced apoptosis in vascular smooth muscle cells
09/19/1996CA2214779A1 Use of nitric oxide donor and/or substrate for inducing cervical dilation
09/19/1996CA2213749A1 Adenosine as a positive inotrop in the compromised heart
09/18/1996EP0731811A1 Chaperonin 10
09/18/1996EP0731712A1 Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents
09/18/1996EP0731708A1 Extract from the leaves of ginkgo biloba
09/18/1996EP0731694A1 Opioid formulations for treating pain
09/18/1996EP0637964B1 Drugs for tumour therapy in conjunction control with and regulation of the immune system and use of the individual substances for combined therapy
09/18/1996EP0531370B1 Inhibition of viral infection
09/18/1996CN1131392A Nitric oxide donor composition and method for treatment of anal disorders
09/17/1996US5556882 Methods of treating wrinkles using benzilic acid
09/17/1996US5556838 Blocking n-methylaspartate receptors to prevent addiction
09/17/1996US5556763 Patterns of transcription factors and lymphocytes
1 ... 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 ... 1151